Sparking New Discoveries for Parkinson’s Disease
The Collaborative Research Network (CRN) is a first-of-its-kind global community of multidisciplinary and multi-institutional teams working together to spark new discoveries in Parkinson’s disease (PD) research. The CRN is a program of the Aligning Science Across Parkinson’s (ASAP) initiative, managed by the Coalition for Aligning Science and implemented by the Michael J. Fox Foundation.
Our Research Network
The ASAP CRN supports 67 research teams across 24 countries, focusing on critical areas such as functional genomics in Parkinson’s disease, neuro-immune interactions, circuitry and brain-body interactions, PD heterogeneity, and tool generation. With collaboration at its core, the CRN brings together hundreds of investigators to share expertise, findings, and tools in an effort to tackle challenges in the PD space. As a community, we promote standards for openness, real-world utility, and collective impact across scientific research.
An ASAP Program
An ASAP Program
The Aligning Science Across Parkinson’s (ASAP) initiative launched the CRN in 2020 to catalyze breakthroughs in PD research. ASAP fosters connections across the scientific community by supporting a variety of programs designed to enhance collaboration and promote sharing of scientific findings, tools, and technologies.
Impact
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
Impact
From the beginning, the CRN has been committed to providing resources, addressing research bottlenecks, and fostering innovation to build a thriving research ecosystem that advances Parkinson’s disease research.
Latest CRN Highlights
Members of the CRN work diligently to advance our understanding of Parkinson’s disease. Learn more about recent CRN discoveries and achievements.
PPMI Enters a New Era
PPMI now stands for the Parkinson’s Precision Medicine Initiative, reflecting how far the study, and the science, has come. What started as an ambitious effort to track Parkinson’s over time is now helping unlock a more personalized approach to treatment and care.
Gut Microbiome Can Reveal Risk of Parkinson’s, Scientists Say
The Guardian reports on a breakthrough study by CRN Team Schapira, which identified a distinct gut microbial "signature" that can signal Parkinson's risk years before physical symptoms appear.
Aligning Science Across Parkinson’s and The Michael J. Fox Foundation Expand Global Research Initiative with $261M Investment Toward Personalized Treatments
Today, Aligning Science Across Parkinson’s (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), announced $261 million in new grant funding for the Collaborative Research Network (CRN) to map the biological blueprint of Parkinson’s disease and build a standardized toolkit of global research resources that are needed to turn discoveries into treatments.